Ma Weiguo, Wang Zengxi, Li Zhen, Rong Weining, Cui Qianwei, Hu Xuejun
Department of Ophthalmology, People's Hospital of Ningxia Hui Autonomous Region, No. 301, Zhengyuan North Street, Yinchuan, Ningxia Province, 750011, China.
Department of Ophthalmology, Zhongwei City Shapotou District People's Hospital, Zhongwei, 755099, China.
BMC Ophthalmol. 2025 May 30;25(1):322. doi: 10.1186/s12886-025-04121-9.
To assess the therapeutic effect of suprachoroidal viscoelastic injection combined with 532 laser photocoagulation for the closure of retinal tears in the treatment of rhegmatogenous retinal detachment (RRD).
We retrospectively analyzed the clinical data of eight patients with RRD (eight eyes) who underwent suprachoroidal viscoelastic injection combined with 532-nm laser photocoagulation for the closure of tears at our hospital. The outcomes investigated were postoperative visual acuity and retinal reattachment.
The intraocular pressure (IOP) was significantly higher after surgery than before surgery (11.93 mmHg vs. 19.50 mmHg), and the best corrected visual acuity (BCVA) changed from 0.41 to 0.49, suggesting a significant improvement within 3 days post-surgery. In 7/8 eyes, the retina was well reattached postoperatively and follow-ups indicated stable condition. One patient experienced failed retinal reattachment and subsequently underwent vitrectomy combined with silicone oil tamponade. Three months after surgery, the silicone oil was removed, revealing successful reattachment of the retina.
In patients with RRD characterized by smaller retinal tears, more localized retinal detachment, and a proliferative vitreoretinopathy grade of ≤ C1, treatment incorporating suprachoroidal viscoelastic injection and 532-nm laser photocoagulation to seal the tears resulted in good postoperative recovery, with all patients achieving favorable visual acuity. However, due to the retrospective, non-comparative design without a control group, it is difficult to fully evaluate the relative efficacy of this treatment compared to other methods.
Not applicable.
评估脉络膜上腔粘弹性注射联合532激光光凝治疗孔源性视网膜脱离（RRD）中视网膜裂孔封闭的治疗效果。
我们回顾性分析了我院8例RRD患者（8只眼）接受脉络膜上腔粘弹性注射联合532nm激光光凝封闭裂孔的临床资料。研究的结果指标为术后视力和视网膜复位情况。
术后眼压（IOP）显著高于术前（11.93mmHg对19.50mmHg），最佳矫正视力（BCVA）从0.41提高到0.49，表明术后3天内有显著改善。8只眼中7只术后视网膜复位良好，随访显示情况稳定。1例患者视网膜复位失败，随后接受了玻璃体切除术联合硅油填充。术后3个月，取出硅油，视网膜成功复位。
对于RRD患者，若其视网膜裂孔较小、视网膜脱离局限且增生性玻璃体视网膜病变等级≤C1，采用脉络膜上腔粘弹性注射联合532nm激光光凝封闭裂孔的治疗方法术后恢复良好，所有患者视力均得到改善。然而，由于本研究为回顾性、非对比性设计且无对照组，难以全面评估该治疗方法与其他方法相比的相对疗效。
不适用。
